Hospitals Tara Bannow STAT Plus: The CEO of Kaiser’s new health network shares why he’s making a bet on a tiny North Carolina hospital system
Health Isabella Cueto and Angus Chen STAT Plus: Jury orders Stanford to pay millions to employee in racial harassment case
Health Elizabeth Cooney STAT Plus: Vertex reports positive results in stem cell trial for type 1 diabetes
Exclusive John Wilkerson and Rachel Cohrs Zhang STAT Plus: House panel weighs new plan for Medicare coverage of Wegovy, cancer blood tests
Business Tara Bannow STAT Plus: Kaiser adds a small North Carolina health system to its Risant Health network
Biotech Adam Feuerstein STAT Plus: What the Sarepta decision means for Duchenne patients, the company, and the FDA
Health tech Mohana Ravindranath STAT Plus: Federal judge rules in favor of hospital lobby in privacy lawsuit
Pharmalot Ed Silverman STAT Plus: Pharmalittle: We’re reading about FDA approval for Sarepta drug, MSF closing access campaign and more
Health Timmy Broderick Supreme Court outlawed segregation of disabled people 25 years ago. But change has come slowly
First Opinion Zoe Adams and Asher Levinthal Medical experts must step up if health justice is to enter the courtroom
Biotech Jason Mast and Matthew Herper STAT Plus: Top FDA official Peter Marks overruled staff, review team to approve Sarepta gene therapy
Biotech Jonathan Saltzman — Boston Globe STAT Plus: Ginkgo Bioworks lays off 158 employees, with more to come
Health tech Brittany Trang Change Healthcare to begin notifying patients that cyberattack compromised their private info
Pharmalot Ed Silverman STAT Plus: Vertex reaches a new deal with NHS England over its pricey cystic fibrosis treatments
The Readout LOUD Allison DeAngelis and Adam Feuerstein Listen: Fauci’s memoir, Alnylam’s tenuous trial, and a mid-year review
In the Lab Angus Chen STAT Plus: New immunotherapy combination could ‘change the landscape’ of cancer treatment
In the Lab Usha Lee McFarling Coalition wages campaign for retractions of Richard Lynn’s racist journal articles
Exclusive Ed Silverman STAT Plus: Doctors Without Borders is closing its widely regarded access-to-medicines campaign
Pharmalot Ed Silverman STAT Plus: Pharmalittle: We’re reading about Lilly lawsuits, Novo Nordisk fires and much more
Biotech Jason Mast STAT Plus: Gilead’s twice-yearly antiviral protected women from HIV infection in large trial
Adam's Biotech Scorecard Adam Feuerstein STAT Plus: A primer on HELIOS-B, an enormous stock-moving event for Alnylam Pharmaceuticals